Irsenontrine
Modify Date: 2024-04-11 10:52:14
Irsenontrine structure
|
Common Name | Irsenontrine | ||
|---|---|---|---|---|
| CAS Number | 1429509-82-9 | Molecular Weight | 390.44 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H22N4O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of IrsenontrineIrsenontrine (E2027) is an orally active and selective phosphodiesterase 9 (PDE 9) inhibitor. Irsenontrine can be used for the research of neurological diseases[1]. |
| Name | Irsenontrine |
|---|
| Description | Irsenontrine (E2027) is an orally active and selective phosphodiesterase 9 (PDE 9) inhibitor. Irsenontrine can be used for the research of neurological diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
PDE 9[1] |
| In Vitro | Irsenontrine (E2027) is an orally active and selective phosphodiesterase 9 (PDE 9) inhibitor[1]. |
| References |
| Molecular Formula | C22H22N4O3 |
|---|---|
| Molecular Weight | 390.44 |